Patents by Inventor James Kyle Zorn

James Kyle Zorn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drug compositions
    Patent number: 11564910
    Abstract: Described herein are pharmaceutical compositions including omeprazole and a benzimidazole drug. In some embodiments, the compositions can be formulated for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: January 31, 2023
    Assignee: Adamis Pharmaceuticals Corporation
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • DRUG COMPOSITIONS
    Publication number: 20220000876
    Abstract: Described herein are pharmaceutical compositions including in combination at least one antiparasitic drug and one antiprotozoal drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat neurological conditions. Methods of treatment using the compositions are also described.
    Type: Application
    Filed: November 1, 2019
    Publication date: January 6, 2022
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • DRUG COMPOSITIONS
    Publication number: 20210267945
    Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. Methods using the compositions are also described.
    Type: Application
    Filed: May 14, 2021
    Publication date: September 2, 2021
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • DRUG COMPOSITIONS
    Publication number: 20210205270
    Abstract: Described herein are pharmaceutical compositions including omeprazole and a benzimidazole drug. In some embodiments, the compositions can be formulated for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.
    Type: Application
    Filed: December 7, 2018
    Publication date: July 8, 2021
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • Drug compositions
    Patent number: 11045450
    Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.
    Type: Grant
    Filed: September 4, 2019
    Date of Patent: June 29, 2021
    Assignee: Adamis Pharmaceuticals Corporation
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • DRUG COMPOSITIONS
    Publication number: 20200138823
    Abstract: Described herein are pharmaceutical compositions including in combination at least one antiparasitic drug and one antiprotozoal drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat neurological conditions. Methods of treatment using the compositions are also described.
    Type: Application
    Filed: November 1, 2019
    Publication date: May 7, 2020
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • DRUG COMPOSITIONS
    Publication number: 20190388396
    Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.
    Type: Application
    Filed: September 4, 2019
    Publication date: December 26, 2019
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • Drug compositions
    Patent number: 10441575
    Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.
    Type: Grant
    Filed: March 7, 2018
    Date of Patent: October 15, 2019
    Assignee: Adamis Pharmaceuticals Corporation
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • Drug compositions comprising an anti-parasitic and proton pump inhibitor
    Patent number: 10137111
    Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: November 27, 2018
    Assignee: Adamis Pharmaceuticals Corporation
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • DRUG COMPOSITIONS
    Publication number: 20180193316
    Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.
    Type: Application
    Filed: March 7, 2018
    Publication date: July 12, 2018
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • DRUG COMPOSITIONS COMPRISING AN ANTI-PARASITIC AND PROTON PUMP INHIBITOR
    Publication number: 20180042901
    Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.
    Type: Application
    Filed: August 11, 2017
    Publication date: February 15, 2018
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo